Discovery and Characterization of Hydroxysteroid 17-β Dehydrogenase 13 Inhibitors

Characterization of Mouse and Human HSD17B13 Structure and Activity

EDP-235, a Potent and Once-Daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes with the Potential for Mitigation of Cytokine Storm in COVID-19 Patients

EDP-235, a Potent and Once-Daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes with the Potential for Mitigation of Cytokine Storm in COVID-19 Patients

EDP-235, a Potent, Once-Daily Oral Antiviral Treatment for COVID-19

EDP-323, a Small Molecule L-Protein Inhibitor, in Development Against Respiratory Syncytial Virus

EDP-323, a Novel L-Protein Inhibitor, for the Treatment of Respiratory Syncytial Virus

In Vivo Efficacy of EDP-323, a Novel L-Protein Inhibitor, for the Treatment of Respiratory Syncytial Virus

An Improved Toolkit for In Vitro hMPV Characterization

Evaluation of a Human 3D Airway Tissue Culture Model for the Study of Respiratory Syncytial Virus Infection and the Development of Antiviral Drugs